annual EBIT:
-$503.01M-$34.44M(-7.35%)Summary
- As of today (July 2, 2025), CYTK annual earnings before interest & taxes is -$503.01 million, with the most recent change of -$34.44 million (-7.35%) on December 31, 2024.
- During the last 3 years, CYTK annual EBIT has fallen by -$317.03 million (-170.46%).
- CYTK annual EBIT is now -2103.80% below its all-time high of $25.10 million, reached on December 31, 2009.
Performance
CYTK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$138.43M-$11.00M(-8.64%)Summary
- As of today (July 2, 2025), CYTK quarterly earnings before interest & taxes is -$138.43 million, with the most recent change of -$11.00 million (-8.64%) on March 1, 2025.
- Over the past year, CYTK quarterly EBIT has dropped by -$20.11 million (-16.99%).
- CYTK quarterly EBIT is now -346.89% below its all-time high of $56.07 million, reached on June 30, 2009.
Performance
CYTK quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$523.12M-$20.11M(-4.00%)Summary
- As of today (July 2, 2025), CYTK TTM earnings before interest & taxes is -$523.12 million, with the most recent change of -$20.11 million (-4.00%) on March 1, 2025.
- Over the past year, CYTK TTM EBIT has dropped by -$54.27 million (-11.58%).
- CYTK TTM EBIT is now -2040.87% below its all-time high of $26.95 million, reached on September 30, 2009.
Performance
CYTK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CYTK EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.3% | -17.0% | -11.6% |
| 3 y3 years | -170.5% | -72.8% | -131.7% |
| 5 y5 years | -433.2% | -364.2% | -393.1% |
CYTK EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -170.5% | at low | -1282.9% | at low | -188.7% | at low |
| 5 y | 5-year | -467.6% | at low | -2310.6% | at low | -580.1% | at low |
| alltime | all time | -2103.8% | at low | -346.9% | at low | -2040.9% | at low |
CYTK EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$138.43M(+8.6%) | -$523.12M(+4.0%) |
| Dec 2024 | -$503.01M(+7.3%) | -$127.43M(-7.8%) | -$503.01M(+1.5%) |
| Sep 2024 | - | -$138.25M(+16.2%) | -$495.42M(+4.8%) |
| Jun 2024 | - | -$119.02M(+0.6%) | -$472.60M(+0.8%) |
| Mar 2024 | - | -$118.32M(-1.3%) | -$468.85M(+0.1%) |
| Dec 2023 | -$468.58M(+38.7%) | -$119.83M(+3.8%) | -$468.58M(-0.3%) |
| Sep 2023 | - | -$115.43M(+0.1%) | -$469.86M(-2.3%) |
| Jun 2023 | - | -$115.27M(-2.4%) | -$480.97M(+28.0%) |
| Mar 2023 | - | -$118.05M(-2.5%) | -$375.71M(+11.2%) |
| Dec 2022 | -$337.80M(+81.6%) | -$121.11M(-4.3%) | -$337.80M(+41.5%) |
| Sep 2022 | - | -$126.54M(+1164.2%) | -$238.77M(+31.8%) |
| Jun 2022 | - | -$10.01M(-87.5%) | -$181.20M(-19.8%) |
| Mar 2022 | - | -$80.14M(+262.9%) | -$225.80M(+21.4%) |
| Dec 2021 | -$185.98M(+109.9%) | -$22.08M(-68.0%) | -$185.98M(-6.1%) |
| Sep 2021 | - | -$68.97M(+26.3%) | -$197.98M(+61.3%) |
| Jun 2021 | - | -$54.61M(+35.4%) | -$122.75M(+23.8%) |
| Mar 2021 | - | -$40.32M(+18.3%) | -$99.11M(+11.8%) |
| Dec 2020 | -$88.61M(-6.1%) | -$34.08M(-644.2%) | -$88.61M(+15.2%) |
| Sep 2020 | - | $6.26M(-120.2%) | -$76.91M(-27.5%) |
| Jun 2020 | - | -$30.98M(+3.9%) | -$106.08M(+5.3%) |
| Mar 2020 | - | -$29.82M(+33.3%) | -$100.78M(+6.8%) |
| Dec 2019 | -$94.33M(+11.3%) | -$22.38M(-2.3%) | -$94.33M(+2.0%) |
| Sep 2019 | - | -$22.91M(-10.8%) | -$92.51M(+7.3%) |
| Jun 2019 | - | -$25.67M(+9.8%) | -$86.20M(+4.1%) |
| Mar 2019 | - | -$23.38M(+13.7%) | -$82.81M(-2.3%) |
| Dec 2018 | -$84.72M(-23.5%) | -$20.56M(+23.9%) | -$84.72M(-15.2%) |
| Sep 2018 | - | -$16.59M(-25.6%) | -$99.92M(-10.0%) |
| Jun 2018 | - | -$22.29M(-11.9%) | -$110.97M(-2.0%) |
| Mar 2018 | - | -$25.29M(-29.3%) | -$113.27M(+2.2%) |
| Dec 2017 | -$110.79M(-678.5%) | -$35.75M(+29.3%) | -$110.80M(+64.9%) |
| Sep 2017 | - | -$27.64M(+12.5%) | -$67.17M(+1132.3%) |
| Jun 2017 | - | -$24.58M(+7.7%) | -$5.45M(-166.3%) |
| Mar 2017 | - | -$22.82M(-389.9%) | $8.23M(-57.0%) |
| Dec 2016 | $19.15M(-151.4%) | $7.87M(-76.9%) | $19.15M(+725.8%) |
| Sep 2016 | - | $34.08M(-412.5%) | $2.32M(-105.7%) |
| Jun 2016 | - | -$10.90M(-8.3%) | -$40.61M(+0.8%) |
| Mar 2016 | - | -$11.89M(+32.7%) | -$40.29M(+8.0%) |
| Dec 2015 | -$37.23M(+154.2%) | -$8.96M(+1.3%) | -$37.31M(+88.3%) |
| Sep 2015 | - | -$8.85M(-16.4%) | -$19.82M(+16.8%) |
| Jun 2015 | - | -$10.59M(+18.9%) | -$16.97M(+14.8%) |
| Mar 2015 | - | -$8.91M(-204.5%) | -$14.79M(+0.9%) |
| Dec 2014 | -$14.65M(-56.6%) | $8.53M(-242.2%) | -$14.65M(-11.6%) |
| Sep 2014 | - | -$6.00M(-28.7%) | -$16.57M(-28.5%) |
| Jun 2014 | - | -$8.41M(-4.1%) | -$23.18M(-22.3%) |
| Mar 2014 | - | -$8.77M(-232.7%) | -$29.84M(-11.5%) |
| Dec 2013 | -$33.72M | $6.61M(-152.4%) | -$33.72M(-34.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$12.61M(-16.3%) | -$51.78M(+5.2%) |
| Jun 2013 | - | -$15.07M(+19.1%) | -$49.21M(+14.1%) |
| Mar 2013 | - | -$12.65M(+10.4%) | -$43.12M(+6.7%) |
| Dec 2012 | -$40.37M(-15.6%) | -$11.46M(+14.1%) | -$40.39M(-1.0%) |
| Sep 2012 | - | -$10.04M(+12.0%) | -$40.81M(-1.4%) |
| Jun 2012 | - | -$8.97M(-9.6%) | -$41.40M(-10.1%) |
| Mar 2012 | - | -$9.93M(-16.4%) | -$46.05M(-3.7%) |
| Dec 2011 | -$47.82M(-3.0%) | -$11.87M(+11.7%) | -$47.82M(+0.6%) |
| Sep 2011 | - | -$10.63M(-21.9%) | -$47.54M(-3.8%) |
| Jun 2011 | - | -$13.62M(+16.4%) | -$49.41M(+1.1%) |
| Mar 2011 | - | -$11.70M(+0.9%) | -$48.88M(-0.9%) |
| Dec 2010 | -$49.30M(-296.4%) | -$11.59M(-7.3%) | -$49.30M(-1.4%) |
| Sep 2010 | - | -$12.50M(-4.4%) | -$49.99M(+9.7%) |
| Jun 2010 | - | -$13.08M(+7.9%) | -$45.59M(-293.4%) |
| Mar 2010 | - | -$12.12M(-1.4%) | $23.57M(-6.1%) |
| Dec 2009 | $25.10M(-144.9%) | -$12.29M(+51.8%) | $25.10M(-6.9%) |
| Sep 2009 | - | -$8.10M(-114.4%) | $26.95M(+29.4%) |
| Jun 2009 | - | $56.07M(-629.7%) | $20.83M(-140.6%) |
| Mar 2009 | - | -$10.59M(+1.4%) | -$51.28M(-8.2%) |
| Dec 2008 | -$55.88M(-1.1%) | -$10.44M(-26.6%) | -$55.88M(-7.5%) |
| Sep 2008 | - | -$14.22M(-11.3%) | -$60.41M(+1.7%) |
| Jun 2008 | - | -$16.04M(+5.6%) | -$59.38M(+2.5%) |
| Mar 2008 | - | -$15.19M(+1.6%) | -$57.91M(+2.5%) |
| Dec 2007 | -$56.49M(-7.9%) | -$14.96M(+13.3%) | -$56.49M(-3.5%) |
| Sep 2007 | - | -$13.20M(-9.4%) | -$58.51M(-4.6%) |
| Jun 2007 | - | -$14.56M(+5.8%) | -$61.31M(-0.5%) |
| Mar 2007 | - | -$13.76M(-18.9%) | -$61.63M(+0.5%) |
| Dec 2006 | -$61.34M(+37.4%) | -$16.98M(+6.1%) | -$61.34M(+9.4%) |
| Sep 2006 | - | -$16.00M(+7.5%) | -$56.05M(+10.4%) |
| Jun 2006 | - | -$14.89M(+10.6%) | -$50.78M(+8.1%) |
| Mar 2006 | - | -$13.47M(+15.2%) | -$46.99M(+5.3%) |
| Dec 2005 | -$44.63M(+16.1%) | -$11.70M(+9.0%) | -$44.63M(-1.3%) |
| Sep 2005 | - | -$10.73M(-3.4%) | -$45.23M(+0.2%) |
| Jun 2005 | - | -$11.10M(-0.1%) | -$45.15M(+3.6%) |
| Mar 2005 | - | -$11.11M(-9.6%) | -$43.57M(+13.4%) |
| Dec 2004 | -$38.43M(+17.9%) | -$12.29M(+15.3%) | -$38.43M(-42.3%) |
| Sep 2004 | - | -$10.65M(+11.9%) | -$66.67M(+24.9%) |
| Jun 2004 | - | -$9.52M(+59.5%) | -$53.37M(+9.9%) |
| Mar 2004 | - | -$5.97M(-85.3%) | -$48.58M(+2.0%) |
| Dec 2003 | -$32.59M(+35.9%) | -$40.52M(-1632.6%) | -$47.62M(+571.1%) |
| Sep 2003 | - | $2.64M(-155.9%) | -$7.09M(-27.1%) |
| Jun 2003 | - | -$4.73M(-5.5%) | -$9.74M(+94.5%) |
| Mar 2003 | - | -$5.01M | -$5.01M |
| Dec 2002 | -$23.98M(+30.4%) | - | - |
| Dec 2001 | -$18.39M(+33.3%) | - | - |
| Dec 2000 | -$13.79M | - | - |
FAQ
- What is Cytokinetics Incorporated annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual EBIT year-on-year change?
- What is Cytokinetics Incorporated quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly EBIT year-on-year change?
- What is Cytokinetics Incorporated TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM EBIT year-on-year change?
What is Cytokinetics Incorporated annual earnings before interest & taxes?
The current annual EBIT of CYTK is -$503.01M
What is the all time high annual EBIT for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual earnings before interest & taxes is $25.10M
What is Cytokinetics Incorporated annual EBIT year-on-year change?
Over the past year, CYTK annual earnings before interest & taxes has changed by -$34.44M (-7.35%)
What is Cytokinetics Incorporated quarterly earnings before interest & taxes?
The current quarterly EBIT of CYTK is -$138.43M
What is the all time high quarterly EBIT for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly earnings before interest & taxes is $56.07M
What is Cytokinetics Incorporated quarterly EBIT year-on-year change?
Over the past year, CYTK quarterly earnings before interest & taxes has changed by -$20.11M (-16.99%)
What is Cytokinetics Incorporated TTM earnings before interest & taxes?
The current TTM EBIT of CYTK is -$523.12M
What is the all time high TTM EBIT for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM earnings before interest & taxes is $26.95M
What is Cytokinetics Incorporated TTM EBIT year-on-year change?
Over the past year, CYTK TTM earnings before interest & taxes has changed by -$54.27M (-11.58%)